healthways inc (HWAY) Snapshot

Healthways Inc. announced that Donato Tramuto, CEO and Vice Chairman of Physicians Interactive, the leading provider of online and mobile clinical resources and solutions for healthcare professionals, was named to the Healthways Board of Directors. Tramuto is one of the founders of Physicians Interactive and has served as its Chief Executive Officer and Vice Chairman since 2008. Also, he served as President of the Physicians Interactive Division of Allscripts.

Healthways Inc., Annual General Meeting, May 30, 2013., at 09:00 Central Standard Time. Location: Franklin Marriott Cool Springs. Agenda: To elect three directors to hold office for a term of three years or until their successors have been elected and qualified; to consider and act upon an advisory vote to approve executive compensation; to ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for fiscal 2013; to consider and act upon a proposal regarding the declassification of the company’s board of directors; and to transact such other business as may properly come before the meeting, or any adjournment or postponement thereof.

Healthways Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the period, the company reported revenues of $165,165,000 against $165,218,000 for the same period in the last year. Operating loss was $2,723,000 against $929,000 for the same period in the last year. Loss before income taxes was $6,044,000 against $4,116,000 for the same period in the last year. Net loss was $3,949,000 or $0.12 per basic and diluted share against $2,665,000 or $0.08 per basic and diluted share for the same period in the last year. Net cash flows provided by operating activities were $26,029,000 against net cash flows used in operating activities of $11,574,000 for the same period in the last year. Acquisition of property and equipment (capital expenditures) was $11,264,000 against $15,085,000 for the same period in the last year. Free cash flow contributed to a $21.5 million net debt reduction from the end of 2012. Based on the company's first quarter financial and operating results and its outlook for the remainder of 2013, the company affirmed its previously issued financial guidance for 2013. The company's guidance for 2013 revenues is a range of $710 million to $750 million. This range represents a 5% to 11% increase over 2012 revenues, despite reduced revenues of approximately $80 million in 2013, as compared to 2012, from the two terminated contracts. The company expects its revenues to grow sequentially throughout 2013, particularly in the second half of the year. This sequential growth is driven primarily by the significant contracts signed in 2012 that are expected to ramp for as long as 24 to 36 months before reaching an average target revenue run rate. In addition, a vast majority of the company's performance-based revenue for 2013 is expected to be recognized in the second half of the year. As previously discussed, the company expects its existing contract base at the end of 2012 to produce revenue growth for 2014 over 2013 of more than $85 million, before considering any future contract wins or losses. The company continues to expect to produce net cash flows from operations of $70 million to $80 million for 2013, with anticipated capital expenditures of $45 million. The company's guidance for 2013 EBITDA margin remains in a range of 10.5% to 12.5%, compared to an EBITDA margin of 11.9% for 2012. In addition to the impact of the two terminated contracts, the company's EBITDA margin guidance reflects the fact that, for many of the large contracts signed during 2012, implementation costs are incurred ahead of the revenue ramp anticipated during 2013. As a result of these dynamics, the company expects expansion in EBITDA margin through the sequential quarters of 2013. The company's guidance for 2013 net income per diluted share remains in the range of $0.25 to $0.35. Consistent with guidance for 2013 EBITDA, the company expects net income per diluted share to ramp through the sequential quarters of 2013, including a net loss of approximately $0.05 per share for the second quarter of the year before returning to profitability in the third quarter.